https://www.pharmnovo.com https://www.pharmnovo.com/pain-therapy-market/chronic-pain https://www.pharmnovo.com/pain-therapy-market/current-state https://www.pharmnovo.com/disclaimer https://www.pharmnovo.com/about-us/founder https://www.pharmnovo.com/get-in-touch https://www.pharmnovo.com/latest-news https://www.pharmnovo.com/pain-therapy-market/market-opportunity https://www.pharmnovo.com/therapeutic-focus https://www.pharmnovo.com/about-us/our-history https://www.pharmnovo.com/about-us/our-journey https://www.pharmnovo.com/our-network https://www.pharmnovo.com/therapeutic-focus/our-science https://www.pharmnovo.com/therapeutic-focus/projects https://www.pharmnovo.com/about-us/scientific-advisors https://www.pharmnovo.com/therapeutic-focus/scientific-results https://www.pharmnovo.com/about-us https://www.pharmnovo.com/for-investors https://www.pharmnovo.com/news-block https://www.pharmnovo.com/post/17-5m-euro-blended-funding-from-eic https://www.pharmnovo.com/post/22-msek-new-funding https://www.pharmnovo.com/post/67-msek-in-new-funding https://www.pharmnovo.com/post/a-key-step https://www.pharmnovo.com/post/a-stronger-team https://www.pharmnovo.com/post/breaking-new-ground-in-pain-management https://www.pharmnovo.com/post/canada-patent-grant https://www.pharmnovo.com/post/capsules-ready-for-phase-iia-study https://www.pharmnovo.com/post/christmas-bps https://www.pharmnovo.com/post/clinical-phase-i-study-has-started https://www.pharmnovo.com/post/clinical-potential https://www.pharmnovo.com/post/cta-approval-for-pn6047 https://www.pharmnovo.com/post/cta-submission-for-pn6047 https://www.pharmnovo.com/post/ctc-awarded-as-cro https://www.pharmnovo.com/post/endowed-chair-awarded https://www.pharmnovo.com/post/good-press-in-dagens-industri https://www.pharmnovo.com/post/in-memory-of-hans-g https://www.pharmnovo.com/post/jesper-kjerulff-leads-again https://www.pharmnovo.com/post/jpet-approves-pn6047 https://www.pharmnovo.com/post/medicon-village-office https://www.pharmnovo.com/post/meet-jarkko-kalliomaki-chief-medical-officer-pharmnovo https://www.pharmnovo.com/post/meet-jesper-kjerulff-chief-operations-officer-and-global-project-lead https://www.pharmnovo.com/post/meet-olof-breuer-md-clinical-pharmacology-lead https://www.pharmnovo.com/post/meet-our-cmo https://www.pharmnovo.com/post/meet-our-new-cfo https://www.pharmnovo.com/post/moving-into-the-spark https://www.pharmnovo.com/post/new-board-member https://www.pharmnovo.com/post/nida-funds-studies https://www.pharmnovo.com/post/no-abuse-potential-shown-in-preclinical-studies https://www.pharmnovo.com/post/op-team-steps-up https://www.pharmnovo.com/post/pain-symposium-contribution https://www.pharmnovo.com/post/patent-granted-in-china https://www.pharmnovo.com/post/per-von-mentzer-appointed-as-new-ceo https://www.pharmnovo.com/post/pharmnovo-at-biostock https://www.pharmnovo.com/post/pharmnovo-at-the-lsx-nordic-congress https://www.pharmnovo.com/post/pharmnovo-at-the-lsx-world-congress-in-london https://www.pharmnovo.com/post/pharmnovo-attending-lsx-3-4-may https://www.pharmnovo.com/post/pharmnovo-in-naringsliv https://www.pharmnovo.com/post/pharmnovo-in-svenska-dagbladet https://www.pharmnovo.com/post/pharmnovo-live-at-neurology-theme-event-at-redeye https://www.pharmnovo.com/post/pharmnovo-presented-at-the-biostock-investor-meeting https://www.pharmnovo.com/post/pharmnovo-presents-new-results-at-efic-in-budapest https://www.pharmnovo.com/post/pharmnovo-strengthens-the-team https://www.pharmnovo.com/post/phase-i-study-completed-for-pn6047 https://www.pharmnovo.com/post/phase-iia-studies-with-wct https://www.pharmnovo.com/post/pioneering-approach-to-treat-neuropathic-pain https://www.pharmnovo.com/post/pn6047-and-respiratory-depression https://www.pharmnovo.com/post/positiv-fda-feedback-for-pn6047 https://www.pharmnovo.com/post/positive-final-phase-i-results https://www.pharmnovo.com/post/presentation-from-pharmnovo-at-the-global-forum https://www.pharmnovo.com/post/research-collaboration https://www.pharmnovo.com/post/season-greetings-2022 https://www.pharmnovo.com/post/the-clinical-trial-application-cta-has-been-submitted https://www.pharmnovo.com/post/visionaries-in-pain-relief-pharmnovo-presents-bengt-von-mentzer-founder-and-chief-scientific-advisor https://www.pharmnovo.com/post/visionaries-in-pain-relief-pharmnovo-presents-david-kendall-chief-scientific-officer https://www.pharmnovo.com/post/watch-pharmnovo-at-the-lsx-world-congress-europe-in-lisbon-march-2026 https://www.pharmnovo.com/post/welcome-on-board https://www.pharmnovo.com/member/agusta-gudjonsdottir https://www.pharmnovo.com/member/alexander-dahlquist https://www.pharmnovo.com/member/andrew-rice https://www.pharmnovo.com/member/andrew-russo https://www.pharmnovo.com/member/ann-christine-korsgaard https://www.pharmnovo.com/member/anthony-p-d-ford https://www.pharmnovo.com/member/bengt-von-mentzer https://www.pharmnovo.com/member/bjorn-dahl https://www.pharmnovo.com/member/bo-olsson https://www.pharmnovo.com/member/carl-magnus-andersson https://www.pharmnovo.com/member/david-finn https://www.pharmnovo.com/member/david-kendall https://www.pharmnovo.com/member/eamon-kelly https://www.pharmnovo.com/member/helen-pettersson https://www.pharmnovo.com/member/ingemar-starke https://www.pharmnovo.com/member/jarkko-kalliomaki https://www.pharmnovo.com/member/jen-kendall https://www.pharmnovo.com/member/jesper-kjerulff https://www.pharmnovo.com/member/johan-dighed https://www.pharmnovo.com/member/johan-lund https://www.pharmnovo.com/member/karin-rosen https://www.pharmnovo.com/member/kerstin-kenne https://www.pharmnovo.com/member/marianne-svard https://www.pharmnovo.com/member/nanna-finnerup https://www.pharmnovo.com/member/olof-breuer https://www.pharmnovo.com/member/peder-andersson https://www.pharmnovo.com/member/per-von-mentzer https://www.pharmnovo.com/member/petra-larson-2 https://www.pharmnovo.com/member/rikke-winther https://www.pharmnovo.com/member/roger-knaggs https://www.pharmnovo.com/member/stefan-ingelsson https://www.pharmnovo.com/member/thomas-eskildsen https://www.pharmnovo.com/member/tine-kold-olesen https://www.pharmnovo.com/member/tobias-rein https://www.pharmnovo.com/member/urban-fagerholm https://www.pharmnovo.com/member/zsuzanna-helyes https://www.pharmnovo.com/team/board-of-directors https://www.pharmnovo.com/team/business-advisors https://www.pharmnovo.com/team/chemistry-and-formulation https://www.pharmnovo.com/team/clinical https://www.pharmnovo.com/team/key-opinion-leaders https://www.pharmnovo.com/team/operational-team https://www.pharmnovo.com/team/pain https://www.pharmnovo.com/team/regulatory https://www.pharmnovo.com/team/toxicology